Is the ByHeart botulism outbreak over?

CDC Says the Immediate Threat Has Passed — Probe Continues

Federal health authorities have concluded the cluster of botulism cases tied to a baby‑formula brand is no longer active, but the work to determine how contamination happened is ongoing. The U.S. Centers for Disease Control and Prevention has declared the outbreak over after tracing cases and observing no new linked illnesses for a period consistent with the investigation’s threshold.

Investigators and regulators are still focused on answering how the product became contaminated and whether manufacturing, an ingredient, or distribution played a role. Those follow‑up steps include laboratory testing, reviews of production and supply‑chain records, and coordination with state health departments. No definitive root cause has been released yet.

What this means now:

• Continued inspections and testing aimed at identifying the contamination pathway.
• Potential regulatory or enforcement actions depending on what investigators find.
• Ongoing recalls or product holds if further evidence implicates additional lots or ingredients.

Parents and caregivers who used the affected formula should follow current public‑health advice and keep in touch with their pediatrician if they have health concerns. Health systems and regulators will also use findings from this probe to shape guidance and preventive measures for infant‑formula safety more broadly.

Although the immediate outbreak has been declared over, the situation is not closed in a policy sense: the final investigation outcomes will determine whether changes are required in manufacturing controls, ingredient sourcing, or import supervision to prevent a repeat. It’s still unclear which specific breakdown triggered the contamination, and authorities say they will release more information as the probe yields verified results.